The Depo-Provera birth control shot has been linked to an increased risk of a type of brain tumors known as meningiomas. Women who received the Depo shot and were diagnosed with meningioma brain ...

Women injected with the Depo-Provera birth control shot are more than five-times more likely to be diagnosed with a type of brain tumors known as meningioma, according to a recent study. Several ...

According to the Centers for Disease Control and Prevention (CDC), as of 2017, 65.3% of women between the ages of 15 and 49 in the United States use a form of birth control. Of this population, 10.4% ...

Lawsuits allege that the defendants manufactured, promoted, and sold the prescription drug Depo-Provera without adequately warning of its connection to the development of meningiomas, a type of brain ...

WESTWEGO, Louisiana — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For ...

Jul. 24, 2025 7:00 AM ETPfizer Inc. (PFE), PFE:CA Mahyar Etminan, one of the authors of ‘the Frey study’, said: “Given the elevated risk of meningioma with medroxyprogesterone, women may opt to ...

Advertisements on the TV news lately have been citing a 2004 lawsuit against Pfizer (where have I heard that name?) over potentially causing a form of brain cancer with its readily available ...

Provera can cause common side effects like headaches and irregular periods. Serious side effects of Provera include jaundice and chest pain. Do not take Provera if you have hormone-sensitive cancers ...

"It could be big. I think it could be as big as some of the others we've gotten here," Anapol Weiss shareholder Kila Baldwin said. In March, neurosurgeons and researchers in France published a large ...

The FDA has approved a label change on the long-acting injectable contraceptive depot medroxyprogesterone acetate, commonly known as Depo-Provera, to warn users of a potential risk of meningioma. The ...

New York, NY - A black-box warning about significant loss in bone-mineral density (BMD) has been added to the US labeling for the injectable depot contraceptive product Depo-Provera ...